Sunosi (solriamfetol) is used to improve wakefulness in adults with narcolepsy or obstructive sleep apnea. Sunosi (solriamfetol) belongs to the drug class called dopamine and norepinephrine reuptake inhibitors, and it's currently only available as a brand-name medication. Sunosi (solriamfetol) is available as tablets that are taken by mouth once daily when you first wake up. Common side effects include headache, a smaller appetite, and nausea.
Extreme daytime sleepiness caused by:
Sunosi (solriamfetol) is a dopamine and norepinephrine reuptake inhibitor. In other words, it blocks the reuptake of dopamine and norepinephrine in the brain. As a result, more dopamine and norepinephrine sticks around in your brain.
It isn't clear how Sunosi (solriamfetol) helps promote wakefulness throughout the day. But it's thought that dopamine and norepinephrine play a role in improving wakefulness.
Sunosi (solriamfetol) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Sunosi (solriamfetol) can raise your blood pressure and heart rate. The risk is higher if you're 65 years or older, if you already have high blood pressure, or if you're taking other medications that can raise your blood pressure or make your heart rate faster. Also, people with kidney problems can't get rid of Sunosi (solriamfetol) from the body as well, causing the medication to stay in the system longer and raising the risk for high blood pressure and fast heart rate. Talk with your prescriber to make sure the medication is safe for you.
It's important to make sure your blood pressure is under control while you're taking Sunosi (solriamfetol) because having elevated blood pressure for a long period of time can put you at risk for serious health problems, like heart attack and stroke.
Talk to your care team about checking your blood pressure and heart rate while you're taking this medication. Keep in mind that high blood pressure doesn't typically cause noticeable symptoms. But call 911 or get medical help right away if you experience chest pain, severe headache, shortness of breath, or weakness on one side of your body. These can be signs of dangerously high blood pressure.
During clinical studies, some people who took Sunosi (solriamfetol) felt anxious, restless (agitated), and irritable. Some also had trouble sleeping. Tell your prescriber if you notice any changes in your mood or sleep patterns. Your prescriber might lower your dose or have you stop taking Sunosi (solriamfetol).
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effect percentages were reported from studies of adults with narcolepsy. These percentages might differ slightly for adults with obstructive sleep apnea.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
No. Sunosi (solriamfetol) isn't classified as a stimulant. But similar to some stimulants, it works to improve wakefulness in people with narcolepsy who struggle with daytime sleepiness. Instead, Sunosi (solriamfetol) belongs to the drug class called dopamine and norepinephine reuptake inhibitors.
Sunosi (solriamfetol) and Adderall are both once-daily medications that are approved to treat narcolepsy. They both raise the amount of chemicals in the brain called norepinephrine and dopamine, but Adderall also raises serotonin levels. These chemicals are thought to help promote wakefulness. Sunosi (solriamfetol) is only approved for adults, whereas Adderall can be used to treat narcolepsy in children as young as 6 years of age. Both medications are controlled substances and have certain federal and state restrictions because of the risk for misuse. Adderall is classified as having a higher potential for misuse than Sunosi (solriamfetol). Talk with your prescriber about the similarities and differences between the two medications for narcolepsy.
In a clinical study, people who took Sunosi (solriamfetol) reported feeling improvements in their narcolepsy symptoms after 3 months of treatment. Another clinical study found that people with obstructive sleep apnea who took the medication also said that their overall well-being improved after 3 months of treatment. Some aspects of health that the researchers of this study specifically looked at in people with sleep apnea were physical and emotional well-being, social functioning, and productivity.
It takes about a day and a half for most of Sunosi (solriamfetol) to clear from your system after a single dose. This time frame is based off of the medication's half-life, which is an estimation of how long it takes for your body to get rid of Sunosi (solriamfetol). The medication might stay in your system longer if you have kidney problems though because the kidneys don't work as well to get rid of the medication from the body.
It can take a few hours for Sunosi (solriamfetol) to work to keep you awake. For both narcolepsy and obstructive sleep apnea, studies show that people who took Sunosi (solriamfetol) had overall improvements in wakefulness after a few weeks of treatment, sometimes as early as after just one week. Follow up with your prescriber about how you feel Sunosi (solriamfetol) is working for you.
Both Sunosi (solriamfetol) and Wakix (pitolisant) can improve excessive daytime sleepiness in adults with narcolepsy. But the two medications can also help with a few other different things. Wakix (pitolisant) is also approved to treat cataplexy (sudden muscle weakness after experiencing strong emotions), another symptom of narcolepsy. On the other hand, Sunosi (solriamfetol) is also approved for improving excessive daytime sleepiness caused by obstructive sleep apnea. In addition, the two medications work a little differently. Sunosi (solriamfetol) raises the amounts of dopamine and norepinephrine in the brain, whereas Wakix (pitolisant) raises the levels of histamine in the brain. Dopamine, norepinephrine, and histamine are natural chemicals that play a role in wakefulness. Speak with your prescriber about comparing the two medications.
There isn't enough information available to know whether Sunosi (solriamfetol) is safe to take during pregnancy. In animal studies, high doses of the medication caused harm to pregnant mothers and their unborn baby. Keep in mind that what happens in animal studies doesn't always reflect what happens in humans, but there's a potential risk for harm. If you're pregnant and you're taking Sunosi (solriamfetol), it's encouraged that you enroll in the Sunosi Pregnancy Registry. This program keeps track of your health outcomes and your baby's, and it helps researchers learn more about how safe the medication is during pregnancy. Enroll in the registry by calling 1-877-283-6220 or by visiting their website.
Discuss with a healthcare professional about the best way to feed your baby while you're taking Sunosi (solriamfetol) if you're breastfeeding or planning to breastfeed. The medication can pass into your breast milk and there's a potential risk for your breastfed baby to have side effects like irritability and sleep problems.
Your dose depends on what condition you’re taking Sunosi (solriamfetol) for.
Your dose might differ if you have kidney problems.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Sunosi (solriamfetol) will not be safe for you to take.